Botulinum Toxin type B

DRUG3 trials

Sponsors

Eisai Co., Ltd., Stanford University, Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC

Conditions

Cerebral PalsyCervical DystoniaSpasmodic Torticollis

Phase 1

DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?

CompletedNCT00238641

Stanford UniversityCerebral Palsy

Start: 2002-01-31End: 2005-05-31Target: 10Updated: 2005-10-13

Phase 2

Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis

CompletedNCT00165776

Eisai Co., Ltd.Cervical Dystonia, Spasmodic Torticollis

Start: 2004-06-30End: 2006-11-30Updated: 2014-03-10

Phase 4

Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia

CompletedNCT00702754

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLCCervical Dystonia

Start: 2001-06-01End: 2008-09-01Updated: 2026-05-11